- Global Pharma News & Resources

Crystal Clear Prospects: Unveiling the Trajectory of Myopia and Presbyopia Treatment Market with an 8.5% CAGR, According to FMI

The market for medical remedies for treating myopia (nearsightedness) and presbyopia (age-related farsightedness) is referred to as the “Myopia and Presbyopia Treatment Market.” These two frequent ocular refractive defects affect a sizable fraction of the world’s population.

Presbyopia is characterised by the deterioration of near vision that comes with ageing, whereas myopia is a disorder where people have trouble seeing clearly distant things. The quality of life and visual acuity of an individual can both be greatly impacted by these diseases.

Supercharge Your Knowledge: Dive into the Booming Myopia and Presbyopia Treatment Market with Our Sample Report @

By 2022, the market for myopia and presbyopia treatments is predicted to be worth US$ 17.9 billion, growing at a CAGR of 8.5% between 2022 and 2032. By the end of 2032, the market share for myopia and presbyopia treatments is projected to be worth roughly US$ 40.5 billion.

Software and services for workforce management, cost management, and employee engagement are included in these offerings. Additionally, it provides advantages including lower labour costs and workplace regulations. To resolve management problems, a number of healthcare institutions and organisations are employing workforce management systems. During the pandemic era, Future Market Insights (FMI) focused on the expansion and development of the Hospital Workforce Management Market using a multidisciplinary approach. Along with the important conclusions on the prognosis, the study offers insights on the present growth dynamics and the significant revenue reforms now in effect in the market.

By 2020, more than 2.1 billion people will be presbyopic worldwide, according to a global market study of myopia and presbyopia treatment services. According to the World Health Organisation (WHO), by 2020, presbyopia would affect more than 826 million people worldwide. As a result, it is projected that the adoption of myopia and presbyopia treatment services will dramatically rise in emerging nations throughout the course of the projection period.

Key Takeaways Myopia and Presbyopia Treatment Market:

The treatment market for myopia and presbyopia offers a range of options to correct or manage these conditions. Some of the key treatments and interventions available include:

  • Eyeglasses: Traditional eyeglasses with corrective lenses are a common and cost-effective solution for both myopia and presbyopia. They help to focus light properly on the retina, improving vision.
  • Contact lenses: Soft or rigid gas-permeable contact lenses can be prescribed for myopia and presbyopia. Contact lenses provide a wider field of vision compared to eyeglasses and can be suitable for individuals who prefer not to wear glasses.
  • Refractive surgery: Laser-assisted surgeries such as LASIK (Laser-Assisted In Situ Keratomileusis) and PRK (Photorefractive Keratectomy) are popular options for correcting myopia. These procedures reshape the cornea to improve the eye’s focusing power.
  • Intraocular lenses (IOLs): For presbyopia, multifocal or accommodating intraocular lenses can be implanted during cataract surgery. These lenses help restore near, intermediate, and distance vision.
  • Orthokeratology (Ortho-K): This treatment involves wearing specially designed gas-permeable contact lenses overnight to temporarily reshape the cornea. Ortho-K lenses provide clear vision during the day without the need for glasses or contact lenses.
  • Pharmaceutical interventions: Ongoing research is focused on developing pharmaceutical options for myopia control and presbyopia treatment. These may include eye drops or other medications to slow the progression of myopia or restore accommodation in presbyopia.

Global Myopia and Presbyopia Treatment Market Key Players:

  • Ziemer Ophthalmic Systems AG
  • Johnson & Johnson Vision
  • Essilor Ltd.
  • Zeiss International
  • Bausch & Lomb Incorporated
  • Haag-Streit UK
  • Topcon Corporation

Choose Wisdom Through Our Methodology-Driven Insights Now!

Myopia and Presbyopia Treatment Market by Segmentation

By Myopia Treatment Type:

  • Corrective
    • Prescription Lenses
      • Single
      • Bifocal
      • Trifocal
      • Others
    • Contact Lenses
  • Surgical
  • Drugs

By Presbyopia Treatment Type:

  • Prescription Lenses
    • Reading Glasses
    • Bifocals
    • Trifocals
    • Progressive Multifocal
    • Office Progressives
  • Contact Lenses
    • Bifocal
    • Multifocal
    • Monovision
    • Modified Monovision
  • Intraocular Lenses
  • Refractive Surgery

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

Editor Details

Last Updated: 18-Sep-2023